Similar articles for PMID: 24809778

Year	Number of Results
1991	1
1992	1
1993	1
1994	2
1995	1
1996	2
2000	1
2007	1
2008	2
2009	3
2010	6
2011	6
2012	3
2013	10
2014	11
2015	10
2016	13
2017	9
2018	14
2019	12
2020	8
2021	13
2022	5
2024	0

1

Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.

Jin P, Civini S, Zhao Y, De Giorgi V, Ren J, Sabatino M, Jin J, Wang H, Bedognetti D, Marincola F, Stroncek D. Jin P, et al. Br J Cancer. 2014 Jun 10;110(12):2955-64. doi: 10.1038/bjc.2014.235. Epub 2014 May 8. Br J Cancer. 2014. PMID: 24809778 Free PMC article.

2

Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.

Kadle RL, Abdou SA, Villarreal-Ponce AP, Soares MA, Sultan DL, David JA, Massie J, Rifkin WJ, Rabbani P, Ceradini DJ. Kadle RL, et al. PLoS One. 2018 Mar 7;13(3):e0193178. doi: 10.1371/journal.pone.0193178. eCollection 2018. PLoS One. 2018. PMID: 29513756 Free PMC article.

3

Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.

Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB. Prasanna SJ, et al. PLoS One. 2010 Feb 2;5(2):e9016. doi: 10.1371/journal.pone.0009016. PLoS One. 2010. PMID: 20126406 Free PMC article.

4

Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.

Ciccocioppo R, Cangemi GC, Kruzliak P, Gallia A, Betti E, Badulli C, Martinetti M, Cervio M, Pecci A, Bozzi V, Dionigi P, Visai L, Gurrado A, Alvisi C, Picone C, Monti M, Bernardo ME, Gobbi P, Corazza GR. Ciccocioppo R, et al. Stem Cell Res Ther. 2015 Jul 24;6(1):137. doi: 10.1186/s13287-015-0122-1. Stem Cell Res Ther. 2015. PMID: 26206376 Free PMC article.

5

IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.

Chinnadurai R, Copland IB, Patel SR, Galipeau J. Chinnadurai R, et al. J Immunol. 2014 Feb 15;192(4):1491-501. doi: 10.4049/jimmunol.1301828. Epub 2014 Jan 8. J Immunol. 2014. PMID: 24403533

6

Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.

Ling W, Zhang J, Yuan Z, Ren G, Zhang L, Chen X, Rabson AB, Roberts AI, Wang Y, Shi Y. Ling W, et al. Cancer Res. 2014 Mar 1;74(5):1576-87. doi: 10.1158/0008-5472.CAN-13-1656. Epub 2014 Jan 22. Cancer Res. 2014. PMID: 24452999 Free PMC article.

7

Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.

Yañez R, Oviedo A, Aldea M, Bueren JA, Lamana ML. Yañez R, et al. Exp Cell Res. 2010 Nov 15;316(19):3109-23. doi: 10.1016/j.yexcr.2010.08.008. Epub 2010 Sep 8. Exp Cell Res. 2010. PMID: 20804749

8

Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.

Pfeifer S, Schreder M, Bolomsky A, Graffi S, Fuchs D, Sahota SS, Ludwig H, Zojer N. Pfeifer S, et al. J Cancer Res Clin Oncol. 2012 Nov;138(11):1821-30. doi: 10.1007/s00432-012-1259-2. Epub 2012 Jun 22. J Cancer Res Clin Oncol. 2012. PMID: 22722711

9

Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.

Yu Y, Yoo SM, Park HH, Baek SY, Kim YJ, Lee S, Kim YL, Seo KW, Kang KS. Yu Y, et al. J Tissue Eng Regen Med. 2019 Oct;13(10):1792-1804. doi: 10.1002/term.2930. Epub 2019 Jul 25. J Tissue Eng Regen Med. 2019. PMID: 31293088

10

NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.

Ghosh T, Nandi P, Ganguly N, Guha I, Bhuniya A, Ghosh S, Sarkar A, Saha A, Dasgupta S, Baral R, Bose A. Ghosh T, et al. Stem Cell Res Ther. 2019 Sep 23;10(1):296. doi: 10.1186/s13287-019-1349-z. Stem Cell Res Ther. 2019. PMID: 31547863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year